Background illustration for clinical trials search

Oncology Clinical Trials

Browse 9,276 oncology clinical trials enrolling across the United States and Canada. 219 people applied to oncology studies last month. Search by city or state to find one near you.

Filter
1
New

A Study to Evaluate Safety and Clinical Activity of GSK5926371 in Adult Participants With Relapsed or Refractory B-NHL

for
Lymphoma, Non-Hodgkin
Location: New York NY, Toronto, Canton OH, Iowa City IA
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT07607925

Phase 1, Phase 2, Recruiting
New

Belinostat in Combination With Azacitidine or Pralatrexate for the Treatment of Relapse or Refractory T-cell Lymphoma

for
Recurrent Anaplastic Large Cell Lymphoma,
Location: Newnan GA, Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT07691450

Phase 1, Recruiting

Retifanlimab with Bevacizumab and Hypofractionated Radiotherapy for the Treatment of Recurrent Glioblastoma

for
Recurrent Glioblastoma, Recurrent WHO Grade 4 Glioma
Location: Rochester MN
Sponsor: Academic and Community Cancer Research United

Sex: All

Age: 18+

Code: NCT06160206

Phase 2, Recruiting
New

Prospective Collection And Molecular Analysis Of Biospecimens And Clinical Data From Patients With Urothelial Carcinoma And Related Malignancies Of The Urinary Tract

for
Urothelial Carcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07789119

Recruiting

Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations

for
GATA2, Immunodeficiency, MDS
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 6 - 70

Code: NCT01861106

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
New

ABBV-383 for the Treatment of Relapsed Refractory Waldenström Macroglobulinemia

for
Recurrent Waldenstrom Macroglobulinemia,
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT07420959

Phase 1, Phase 2, Recruiting

Trial of Differential Margins in Single Isocenter Radiosurgery of Brain Metastases

for
Brain Metastases
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham

Sex: All

Age: 19+

Code: NCT06857006

Recruiting
New

Evaluating the Effect of Nicotine on Eye Movements and Related Behaviors in Electronic Cigarette Users, NICS-EYES Trial

for
Cigarette Smoking-Related Carcinoma
Location: Columbus OH
Sponsor: Ohio State University Comprehensive Cancer Center

Sex: All

Age: 21 - 50

Code: NCT07604246

Recruiting

Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer

for
HIV, Kaposi's Sarcoma, Lymphomas,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT00006518

Recruiting

Buccal Film vs IV Palonosetron for Prevention of CINV in Cancer Patients Receiving MEC

for
Chemotherapy-induced Nausea and Vomiting
Location: Bethesda MD, Gettysburg PA, Miami Lakes FL, Savannah GA,
Sponsor: Xiamen LP Pharmaceutical Co., Ltd

Sex: All

Age: 18+

Code: NCT05199818

Phase 3, Recruiting
New

Intraoperative Methadone for the Management of Postoperative Pain in Patients With Head and Neck Cancers

for
Head and Neck Carcinoma, Hypopharyngeal Carcinoma,
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute

Sex: All

Age: 18 - 70+

Code: NCT07857655

Recruiting
New

Multimodal Analgesic Regimen for Total Hip Arthroplasty: An Initiative to Minimize Postoperative Opioid Use

for
Arthroplasty, Replacement, Hip
Location: Detroit MI
Sponsor: Henry Ford Health System

Sex: All

Age: 18+

Code: NCT07672808

Recruiting

Active Surveillance for Cancer of the Prostate (ASCaP)

for
Prostate Cancer
Location: Los Angeles CA
Sponsor: Jonsson Comprehensive Cancer Center

Sex: Male

Age: 30 - 70+

Code: NCT00949819

Recruiting

Stereotactic Radiosurgery Dose Escalation for Brain Metastases

for
Brain Metastases
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: All

Age: 18+

Code: NCT02390518

Phase 1, Recruiting
New

Ziftomenib + Mezigdomide in Adolesc. and Adults w/ R/R AML

for
KMT2A-rearranged, NPM1-mutant Refractory or Relapsed AML
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 12+

Code: NCT07355335

Phase 1, Recruiting

Developing Restful Environments and Management Strategies for Pediatric Stem Cell Transplant Patients

for
Stem Cell Transplant Complications, Sleep Disturbance
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 9 - 17

Code: NCT06468618

Recruiting

NEO100 and High-Grade Meningioma

for
Residual, Progressive or Recurrent Grade II or III Meningioma
Location: Boston MA, Dallas TX, Los Angeles CA, Santa Monica CA,
Sponsor: Neonc Technologies, Inc.

Sex: All

Age: 12+

Code: NCT05023018

Phase 2, Recruiting
New

A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma

for
Oropharyngeal Carcinoma (OPC)
Location: Orlando FL, Canton OH, Omaha NE
Sponsor: Corbus Pharmaceuticals Inc.

Sex: All

Age: 18+

Code: NCT07768189

Phase 3, Recruiting

A Phase II Study of Loncastuximab Tesirine as Consolidation Strategy in Patients With LBCL in PR After CAR T-cell Therapy

for
Large B-cell Lymphoma, Lymphoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05464719

Phase 2, Recruiting
New

Olfactory Function and Model-Based Behavior in People Living With HIV and SUD

for
HIV, Substance Use Disorder
Location: Baltimore MD
Sponsor: National Institute on Drug Abuse (NIDA)

Sex: All

Age: 18 - 65

Code: NCT07637669

Recruiting

What is oncology?

Oncology is the branch of medicine focused on cancer. Cancer itself is not a single disease. It is a family of more than 100 diseases, from breast cancer and lung cancer to blood cancers like leukemia and lymphoma. What they share is the same basic problem: cells that grow and divide without stopping. About 4 in 10 people in the US will be diagnosed with some form of cancer during their lifetime.

Cancer research moves faster than almost any other field of medicine. Cancer drugs made up about 35% of all new FDA drug approvals in 2025, 16 new medicines in one year. The 5 year survival rate for all cancers combined reached 70% for people diagnosed in 2015 to 2021, a first in US history. And survival for metastatic (spread) cancer has doubled since the mid 1990s, from 17% to 35%. Every one of those gains came through clinical trials.

Who can participate in oncology trials?

Do oncology trial participants get paid?

Types of cancer clinical trials

The stages of cancer, and why they matter for trials

How to enroll in a clinical trial for cancer